Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease
- 18 March 1998
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 244 (2) , 106-108
- https://doi.org/10.1016/s0304-3940(98)00136-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patientsPublished by Elsevier ,2003
- SOLUBLE INTERLEUKIN-6 RECEPTORS IN HEMATOLOGY PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION1Transplantation, 1996
- Circulating Interleukin-6 Receptor in Patients with Sepsis SyndromeThe Journal of Infectious Diseases, 1995
- The soluble interleukin‐6 receptor is generated by sheddingEuropean Journal of Immunology, 1993
- The participation of interleukin-6 in the pathogenesis of alzheimer's diseaseResearch in Immunology, 1992
- The hepatic interleukin‐6 receptor Down‐regulation of the interleukin‐6 binding subunit (gp80) by its ligandFEBS Letters, 1992
- Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated ‘acute phase response’ in the brain?Immunology Today, 1991
- The molecular pathology of Alzheimer's diseaseNeuron, 1991
- T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor.The Journal of Experimental Medicine, 1988
- Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1987